Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Increased levels of α2-3- and α2-6-linked sialic acids during airway inflammation govern influenza A binding to peripheral airway mucins in a subtype-dependent manner

Benktander, John ; Hayashi, Macarena Paz Quintana ; Nordén, Rickard ; Pettersson, Lisa ; Paulsson, Magnus LU orcid ; Lindén, Anders and Lindén, Sara K. (2026) In Frontiers in Immunology 17.
Abstract

Background: Influenza infection increases the risk of pneumonia and respiratory failure in chronic obstructive pulmonary disease (COPD) and mucins play an important role in pulmonary host defense. Methods: Lower airway mucins were obtained from long-term smokers with and without COPD, pneumonia patients, and healthy never-smokers; oral MUC5B was obtained from a healthy never-smoker, and the ability of lower airway mucins and oral MUC5B to bind influenza A virus (H1N1 and H3N2) was investigated. Results: Lower airway mucins from long-term smokers with and without COPD, as well as the oral MUC5B, bound to H1N1. In contrast, all mucins, regardless of donors, bound to H3N2. Differences in binding were linked to more pronounced glycan... (More)

Background: Influenza infection increases the risk of pneumonia and respiratory failure in chronic obstructive pulmonary disease (COPD) and mucins play an important role in pulmonary host defense. Methods: Lower airway mucins were obtained from long-term smokers with and without COPD, pneumonia patients, and healthy never-smokers; oral MUC5B was obtained from a healthy never-smoker, and the ability of lower airway mucins and oral MUC5B to bind influenza A virus (H1N1 and H3N2) was investigated. Results: Lower airway mucins from long-term smokers with and without COPD, as well as the oral MUC5B, bound to H1N1. In contrast, all mucins, regardless of donors, bound to H3N2. Differences in binding were linked to more pronounced glycan sialylation in lower airway mucins from pneumonia patients and long-term smokers compared with healthy never-smokers. For lower airway mucins, the abundance of α2-6-linked NeuAc correlated with H1N1 binding, whereas the abundance of α2-3-linked NeuAc correlated with H3N2 binding. A neuraminidase inhibitor increased virus binding, even more so for H1N1 than for H3N2, resulting in the binding of both H1N1 and H3N2 to all mucins. The H1N1 neuraminidase cleaved α2-3- and α2-6-linked NeuAc to a similar degree, whereas the H3N2 neuraminidase mainly cleaved the α2-6-linked NeuAc. Mucins inhibited influenza A infection in a concentration-dependent manner in airway epithelial cells, although more so for H1N1 than for H3N2. Conclusion: Mucins inhibit influenza infection, and this effect depends on viral subtype. Neuraminidase inhibitors enable mucins with low sialic acid content to preserve their virus-binding ability, thereby underscoring their therapeutic potential.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
BAL, influenza A virus, inhibition, lung, mucins, O-glycan
in
Frontiers in Immunology
volume
17
article number
1768280
publisher
Frontiers Media S. A.
external identifiers
  • scopus:105034526057
  • pmid:41909675
ISSN
1664-3224
DOI
10.3389/fimmu.2026.1768280
language
English
LU publication?
yes
id
ee0ec793-d820-48af-8694-1fd63d9c822b
date added to LUP
2026-05-21 15:30:31
date last changed
2026-06-04 16:28:20
@article{ee0ec793-d820-48af-8694-1fd63d9c822b,
  abstract     = {{<p>Background: Influenza infection increases the risk of pneumonia and respiratory failure in chronic obstructive pulmonary disease (COPD) and mucins play an important role in pulmonary host defense. Methods: Lower airway mucins were obtained from long-term smokers with and without COPD, pneumonia patients, and healthy never-smokers; oral MUC5B was obtained from a healthy never-smoker, and the ability of lower airway mucins and oral MUC5B to bind influenza A virus (H1N1 and H3N2) was investigated. Results: Lower airway mucins from long-term smokers with and without COPD, as well as the oral MUC5B, bound to H1N1. In contrast, all mucins, regardless of donors, bound to H3N2. Differences in binding were linked to more pronounced glycan sialylation in lower airway mucins from pneumonia patients and long-term smokers compared with healthy never-smokers. For lower airway mucins, the abundance of α2-6-linked NeuAc correlated with H1N1 binding, whereas the abundance of α2-3-linked NeuAc correlated with H3N2 binding. A neuraminidase inhibitor increased virus binding, even more so for H1N1 than for H3N2, resulting in the binding of both H1N1 and H3N2 to all mucins. The H1N1 neuraminidase cleaved α2-3- and α2-6-linked NeuAc to a similar degree, whereas the H3N2 neuraminidase mainly cleaved the α2-6-linked NeuAc. Mucins inhibited influenza A infection in a concentration-dependent manner in airway epithelial cells, although more so for H1N1 than for H3N2. Conclusion: Mucins inhibit influenza infection, and this effect depends on viral subtype. Neuraminidase inhibitors enable mucins with low sialic acid content to preserve their virus-binding ability, thereby underscoring their therapeutic potential.</p>}},
  author       = {{Benktander, John and Hayashi, Macarena Paz Quintana and Nordén, Rickard and Pettersson, Lisa and Paulsson, Magnus and Lindén, Anders and Lindén, Sara K.}},
  issn         = {{1664-3224}},
  keywords     = {{BAL; influenza A virus; inhibition; lung; mucins; O-glycan}},
  language     = {{eng}},
  publisher    = {{Frontiers Media S. A.}},
  series       = {{Frontiers in Immunology}},
  title        = {{Increased levels of α2-3- and α2-6-linked sialic acids during airway inflammation govern influenza A binding to peripheral airway mucins in a subtype-dependent manner}},
  url          = {{http://dx.doi.org/10.3389/fimmu.2026.1768280}},
  doi          = {{10.3389/fimmu.2026.1768280}},
  volume       = {{17}},
  year         = {{2026}},
}